These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 25271100)
21. Structural basis for endotoxin neutralization by the eosinophil cationic protein. Pulido D; Garcia-Mayoral MF; Moussaoui M; Velázquez D; Torrent M; Bruix M; Boix E FEBS J; 2016 Nov; 283(22):4176-4191. PubMed ID: 27696685 [TBL] [Abstract][Full Text] [Related]
22. Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. Lehrer RI; Szklarek D; Barton A; Ganz T; Hamann KJ; Gleich GJ J Immunol; 1989 Jun; 142(12):4428-34. PubMed ID: 2656865 [TBL] [Abstract][Full Text] [Related]
23. Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin. Ackerman SJ; Loegering DA; Venge P; Olsson I; Harley JB; Fauci AS; Gleich GJ J Immunol; 1983 Dec; 131(6):2977-82. PubMed ID: 6644025 [TBL] [Abstract][Full Text] [Related]
24. Eosinophil-induced neurotoxicity: the role of eosinophil cationic protein/RNase 3. Navarro S; Boix E; Cuchillo CM; Nogués MV J Neuroimmunol; 2010 Oct; 227(1-2):60-70. PubMed ID: 20619905 [TBL] [Abstract][Full Text] [Related]
25. Eosinophil cationic protein aggregation: identification of an N-terminus amyloid prone region. Torrent M; Odorizzi F; Nogués MV; Boix E Biomacromolecules; 2010 Aug; 11(8):1983-90. PubMed ID: 20690710 [TBL] [Abstract][Full Text] [Related]
26. Effect of eosinophil cationic protein (ECP) on Hodgkin lymphoma cell lines. Glimelius I; Rubin J; Fischer M; Molin D; Amini RM; Venge P; Enblad G Exp Hematol; 2011 Aug; 39(8):850-8. PubMed ID: 21679745 [TBL] [Abstract][Full Text] [Related]
27. Topography studies on the membrane interaction mechanism of the eosinophil cationic protein. Torrent M; Cuyás E; Carreras E; Navarro S; López O; de la Maza A; Nogués MV; Reshetnyak YK; Boix E Biochemistry; 2007 Jan; 46(3):720-33. PubMed ID: 17223693 [TBL] [Abstract][Full Text] [Related]
28. The sulfate-binding site structure of the human eosinophil cationic protein as revealed by a new crystal form. Boix E; Pulido D; Moussaoui M; Nogués MV; Russi S J Struct Biol; 2012 Jul; 179(1):1-9. PubMed ID: 22579681 [TBL] [Abstract][Full Text] [Related]
29. Essential Role of Enzymatic Activity in the Leishmanicidal Mechanism of the Eosinophil Cationic Protein (RNase 3). Abengózar MÁ; Fernández-Reyes M; Salazar VA; Torrent M; de la Torre BG; Andreu D; Boix E; Rivas L ACS Infect Dis; 2022 Jul; 8(7):1207-1217. PubMed ID: 35731709 [TBL] [Abstract][Full Text] [Related]
30. Dual mechanism of bacterial lethality for a cationic sequence-random copolymer that mimics host-defense antimicrobial peptides. Epand RF; Mowery BP; Lee SE; Stahl SS; Lehrer RI; Gellman SH; Epand RM J Mol Biol; 2008 May; 379(1):38-50. PubMed ID: 18440552 [TBL] [Abstract][Full Text] [Related]
31. The coding ECP 434(G>C) gene polymorphism determines the cytotoxicity of ECP but has minor effects on fibroblast-mediated gel contraction and no effect on RNase activity. Rubin J; Zagai U; Blom K; Trulson A; Engström A; Venge P J Immunol; 2009 Jul; 183(1):445-51. PubMed ID: 19542456 [TBL] [Abstract][Full Text] [Related]
32. Insights into the glycosaminoglycan-mediated cytotoxic mechanism of eosinophil cationic protein revealed by NMR. García-Mayoral MF; Canales A; Díaz D; López-Prados J; Moussaoui M; de Paz JL; Angulo J; Nieto PM; Jiménez-Barbero J; Boix E; Bruix M ACS Chem Biol; 2013 Jan; 8(1):144-51. PubMed ID: 23025322 [TBL] [Abstract][Full Text] [Related]
33. Two human host defense ribonucleases against mycobacteria, the eosinophil cationic protein (RNase 3) and RNase 7. Pulido D; Torrent M; Andreu D; Nogués MV; Boix E Antimicrob Agents Chemother; 2013 Aug; 57(8):3797-805. PubMed ID: 23716047 [TBL] [Abstract][Full Text] [Related]
34. The cytotoxicity of eosinophil cationic protein/ribonuclease 3 on eukaryotic cell lines takes place through its aggregation on the cell membrane. Navarro S; Aleu J; Jiménez M; Boix E; Cuchillo CM; Nogués MV Cell Mol Life Sci; 2008 Jan; 65(2):324-37. PubMed ID: 18087674 [TBL] [Abstract][Full Text] [Related]
35. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Wu M; Maier E; Benz R; Hancock RE Biochemistry; 1999 Jun; 38(22):7235-42. PubMed ID: 10353835 [TBL] [Abstract][Full Text] [Related]
36. Cytokine expression in human dermal fibroblasts stimulated with eosinophil cationic protein measured by protein array. Sato T; Soga Y; Yamaguchi T; Meguro M; Maeda H; Tada J; Otani T; Seno M; Takashiba S Asian Pac J Allergy Immunol; 2013 Dec; 31(4):271-6. PubMed ID: 24383969 [TBL] [Abstract][Full Text] [Related]
37. Eosinophil cationic protein: overview of biological and genetic features. de Oliveira PC; de Lima PO; Oliveira DT; Pereira MC DNA Cell Biol; 2012 Sep; 31(9):1442-6. PubMed ID: 22845733 [TBL] [Abstract][Full Text] [Related]
38. Eosinophil cationic protein damages protoscoleces in vitro and is present in the hydatid cyst. Ramos AL; Discipio RG; Ferreira AM Parasite Immunol; 2006 Aug; 28(8):347-55. PubMed ID: 16879306 [TBL] [Abstract][Full Text] [Related]
39. Mechanism of membrane damage mediated by human eosinophil cationic protein. Young JD; Peterson CG; Venge P; Cohn ZA Nature; 1986 Jun 5-11; 321(6070):613-6. PubMed ID: 2423882 [TBL] [Abstract][Full Text] [Related]
40. Antimicrobial activity of human eosinophil granule proteins: involvement in host defence against pathogens. Malik A; Batra JK Crit Rev Microbiol; 2012 May; 38(2):168-81. PubMed ID: 22239733 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]